do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline Comparison of and Clinical Use of DPP-4 Inhibitors
Description
Yamamoto, H

Cardiovasc Ther (2012) 30(3):e14655

The point is not that you should be able to read all the side-effects, but rather impress upon you that all medications have potential side effects, and many have lots of them

Slowed aging associated with the risk of allcause mortality in 34% of participants as measured by the PCGrimAge epigenetic clock

doi: 10.1016/j.amjmed.2015.07.015
